Despite their potential, traditional ABIs have historically delivered underwhelming results. Unlike cochlear implants, which are inserted into the spiraling chamber of the inner ear, ABIs must be placed directly onto the surface of the brainstem. Current clinical models are rigid, paddle-like structures that struggle to conform to the delicate, curved architecture of the cochlear nucleus. This mechanical mismatch often leads to poor electrical contact, forcing clinicians to deactivate a majority of the electrodes to avoid "off-target" stimulation. When the electrical current spreads beyond the intended area, it can trigger the facial nerve or the vestibular system, causing patients to experience uncontrollable facial twitching or debilitating dizziness rather than clear sound. As a result, most ABI users today perceive only environmental "noise" or rhythmic cues, with very few achieving the speech intelligibility common among cochlear implant recipients.
In a transformative study published in Nature Biomedical Engineering, researchers at the École Polytechnique Fédérale de Lausanne (EPFL) have unveiled a new generation of soft, thin-film ABIs that could redefine the future of hearing restoration. Developed at the Laboratory for Soft Bioelectronic Interfaces (LSBI), the device leverages advanced materials science to bridge the gap between rigid electronics and the soft, gelatinous tissue of the human brain.
The Engineering of Soft Bioelectronics
The core innovation of the EPFL team, led by Professor Stéphanie P. Lacour, lies in the material composition and fabrication of the implant. Traditional ABIs utilize relatively thick silicone backings and large, stiff platinum disks. In contrast, the new EPFL device utilizes micrometer-scale platinum electrodes embedded within an ultra-flexible, thin-film silicone matrix. The resulting array is just a fraction of a millimeter thick—comparable to the thickness of a human hair—allowing it to drape over the curved surface of the brainstem like a piece of cling film over a fruit.
This conformability is achieved through microlithography, a high-precision manufacturing technique typically used in the production of computer chips. By applying this process to flexible substrates, the researchers were able to create an array that is not only soft but also highly customizable. "The design freedom of microlithography is enormous," says Alix Trouillet, a former postdoctoral researcher at EPFL and co-first author of the study. "We can envision higher electrode counts or new layouts that further refine frequency-specific tuning."
The current prototype features 11 electrodes, but the scalability of the thin-film process suggests that future iterations could house dozens, or even hundreds, of stimulation points. This increase in electrode density is critical for restoring "high-resolution" hearing, as it allows the device to target the tonotopic map of the cochlear nucleus—the specific regions responsible for different sound frequencies—with unprecedented precision.
Validation Through Complex Behavioral Tasks
To move beyond the limitations of surgical observation, the EPFL team conducted a rigorous series of behavioral experiments using macaques with normal hearing. This phase of the research was essential to determine whether the brain could actually interpret the electrical pulses from the soft ABI as meaningful sound patterns.
Emilie Revol, co-first author and former PhD student at EPFL, spearheaded the behavioral training. The task required the animals to distinguish between different patterns of electrical stimulation, mimicking the way a human would need to distinguish between phonemes in speech. The macaques were trained to interact with a lever: they would press and hold the lever when they heard a "reference" tone and release it only when they detected a change in the sound pattern.
"Half the challenge is coming up with a viable implant; the other half is teaching an animal to show us, behaviorally, what it actually hears," Revol explains. The training process began by blending acoustic tones with electrical stimulation from the soft ABI. Over time, the acoustic component was phased out, leaving only the prosthetic input. The results were striking: the animals were able to detect minute shifts in stimulation between different electrode pairs on the soft array. The behavioral data suggested that the monkeys processed the electrical pulses in a manner nearly identical to natural acoustic sounds, indicating that the soft ABI provides a "cleaner" and more intuitive signal to the brain than its rigid predecessors.
Overcoming the Anatomical Barrier
The dorsal cochlear nucleus (DCN), where an ABI is placed, is a small, complex structure with a radius of approximately 3 millimeters. When a rigid electrode array is placed on this surface, it inevitably leaves microscopic air gaps or pockets of cerebrospinal fluid. To bridge these gaps, higher electrical currents are required, which leads to "current spread." This phenomenon is the primary cause of the side effects that plague current ABI users.
The EPFL team’s soft array eliminates these gaps by following the brainstem’s natural contours. By achieving a perfect "electrode-tissue match," the researchers were able to significantly lower the stimulation thresholds. Lower thresholds mean that less electricity is needed to evoke a response, which in turn prevents the current from leaking into adjacent neural structures, such as the nerves controlling facial muscles or the tongue.
During the macaque trials, the researchers monitored for any signs of discomfort or unintended motor responses. Unlike human patients with rigid ABIs, who often report "tingling" in the face or throat, the test subjects showed no signs of distress. "The monkey pressed the lever to trigger stimulation itself, time and again," Revol notes. "If the prosthetic input had been unpleasant, it probably would have stopped."
Stability and Long-Term Reliability
One of the most significant hurdles in neuroprosthetics is "electrode migration." Because the brainstem is located in a region of the body that experiences constant movement from pulse and respiration, rigid implants often shift over time. Even a movement of a few micrometers can move an electrode away from its target neural population, resulting in a loss of hearing quality or the onset of new side effects.
The EPFL study addressed this by monitoring the position of the soft array over several months. Because the thin-film silicone is so light and adheres so closely to the tissue through surface tension and mechanical compliance, the researchers found no measurable migration. This long-term stability is a prerequisite for any device intended for permanent human implantation.
The Path to Clinical Translation
While the success in macaques marks a pivotal milestone, the transition to human clinics involves a rigorous regulatory and manufacturing journey. Every material used in the device must be certified as medical-grade, and the manufacturing process must be moved into "Clean Room" environments that meet strict ISO standards for medical devices.
Stéphanie P. Lacour and her team are already looking toward the next steps. One immediate strategy involves intraoperative testing in human patients. The team has established partnerships with clinical specialists in Boston who regularly perform ABI surgeries for patients with severe cochlear nerve damage.
"One immediate possibility is to test the device intraoperatively in human ABI surgeries," says Lacour. "They could briefly insert our soft array before the standard implant to measure if we truly reduce stray nerve activation." This "acute" testing in humans would provide the definitive data needed to move toward long-term clinical trials.
Broader Implications for Neurotechnology
The implications of this research extend far beyond hearing restoration. The development of soft, thin-film interfaces represents a broader shift in the field of neuroengineering. As we move toward more sophisticated brain-machine interfaces (BMIs)—intended to treat everything from paralysis to Parkinson’s disease—the need for materials that can "handshake" with neural tissue without causing scarring or inflammation is paramount.
The LSBI at EPFL has been at the forefront of this movement, previously developing soft "e-dura" implants for spinal cord repair. The success of the soft ABI reinforces the theory that mechanical biocompatibility—matching the stiffness of the implant to the stiffness of the brain—is just as important as chemical biocompatibility.
In the context of global health, the refinement of ABI technology could offer a lifeline to thousands of patients who are currently living in total silence. While the cochlear implant changed the landscape of the 20th century, the soft auditory brainstem implant may well be the defining hearing technology of the 21st, finally delivering on the promise of high-resolution, prosthetic hearing for all.
